Pharvaris (PHVS) EPS (Basic) Growth (1y) (2021 - 2026)
Powered by 
Analysis
Pharvaris (PHVS) EPS (Basic) Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn | 87.85% |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | 7.59% |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn | 143.95% |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn | 322.67% |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - | -16.29% |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 96.41% |
| 10 | Pharvaris | 2.15 Bn | 1.78 Bn | 85,072.10 | -3.24% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.24% |
| Mar 31, 2026 | 14.49% |
| Dec 31, 2025 | -34.53% |
| Sep 30, 2025 | 32.79% |
| Jun 30, 2025 | 15.01% |
| Mar 31, 2025 | -14.27% |
| Dec 31, 2024 | 25.56% |
| Sep 30, 2024 | -56.35% |
| Jun 30, 2024 | -100.00% |
| Mar 31, 2024 | -9.34% |
| Dec 31, 2023 | 23.08% |
| Sep 30, 2023 | -178.69% |
| Jun 30, 2023 | 59.19% |
| Mar 31, 2023 | -22.51% |
| Dec 31, 2022 | -157.79% |
| Sep 30, 2022 | 52.34% |
| Jun 30, 2022 | 45,598,227.55% |
| Mar 31, 2022 | -51.84% |
| Dec 31, 2021 | 31.19% |
| Sep 30, 2021 | 36.46% |